Brought to you by FDAnews, get the management report that’s packed with detail-driven advice on how to protect yourself from the risks — while maximizing the rewards — created by the FDA’s newly proposed rules on experimental drugs, Treatment INDs: Responding to Risks Created by Expanded Access.
You’ll discover how to:
Avoid legal issues with experimental drugs when you place your order for Treatment INDs: Responding to Risks Created by Expanded Access. Plus, you’ll get all the facts on adverse events.
After an Adverse Event: Who Will Face a Liability Claim?
Discover full details on adverse events, IRB approval and more, including:
Don’t wait for a liability lawsuit — or the damaging bad press — that can result from adverse events caused by unapproved drugs. Find out where the FDA is headed in Treatment INDs: Responding to Risks Created by Expanded Access.
Don’t wait — capitalize on the rich business opportunities presented by INDs today.
Interested in purchasing more than one print copy?
Significant volume discounts are available for ordering three or more copies of the same book. You must order them at the same time and provide a single payment to take advantage of the discount. Order below by clicking submit and then change your quantity in the shopping cart. The discount will be calculated automatically.
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally with any questions.
Interested in Electronic Multi-user Access?
Phone: +1 (703) 538-7600 or toll free (888) 838-5578